0
0
In a significant and contentious development within India’s healthcare regulatory landscape, the Maharashtra Medical Education and Drugs Department has directed the Maharashtra Medical Council (MMC) to commence the registration of homeopathic practitioners who have completed the one-year Certificate Course in Modern Pharmacology (CCMP). This directive aims to allow these homeopaths to practice limited allopathic medicine under the scope of their CCMP training. The move, announced in early September 2025, has reignited debates over the integration of alternative medicine practitioners into mainstream medical systems and has drawn sharp opposition from sections of the allopathic medical community, notably the Indian Medical Association (IMA) .
Key Developments and Background
The contentious policy traces its origins to a government resolution issued in 2014, which first authorized homeopathic doctors in Maharashtra to undergo a specialized CCMP course under the Maharashtra University of Health Sciences (MUHS), Nashik. The course was designed to equip these practitioners with foundational knowledge of modern pharmacology, enabling them to serve more effectively in public healthcare settings by offering select allopathic treatments where necessary.
Following this, the MMC was empowered to register CCMP-certified homeopathic doctors, allowing them to prescribe allopathic medicines within the training limits of the course. By 2017, the state’s Medical Education and Drugs Department formally permitted these homeopaths to practice modern medicine and register with MMC. However, this triggered strong resistance from the IMA—which represents the allopathic medical fraternity—culminating in legal challenges and a stay order from the Bombay High Court that halted enforcement .
The latest government circular directing MMC to register CCMP-qualified homeopaths comes amid ongoing legal battles and reflects the Attorney General of Maharashtra’s legal opinion supporting the move. The circular stresses the registration process must comply with court rulings but affirms no current orders legally bar the registration and practice under defined limits. This registration could potentially affect up to 90,000 homeopathic practitioners in Maharashtra, marking a sizeable extension of scope for homeopaths traditionally restricted from allopathic medicine .
Expert Commentary and Perspectives
The IMA Maharashtra chapter has vocally condemned the directive. Dr. Santosh Kadam, IMA Maharashtra President, told Medical Dialogues, “We have taken note of the letter and our lawyers are reviewing it. Despite the matter being sub judice, the government has issued a fresh circular to begin registration, which we believe is not right. With the case pending at the Bombay High Court, we will approach the court to expedite the matter” .
Contrastingly, the Maharashtra Homeopathy Council (MHC) hailed the decision as a landmark victory. Bahubali Shah, MHC Administrator, described it as “a victory of truth,” emphasizing that an attempt was made to mislead the government about homeopathy registration but the lawyer’s and judiciary’s opinions prevailed. Shah appealed to eligible homeopaths to register promptly and hailed the move as recognition of the hybrid training and role of modern pharmacology in homeopathic practice .
Independent health policy and medical law experts note the decision highlights a broader national conversation on integrating traditional and alternative medicine systems with allopathy to address healthcare shortages, especially in rural and underserved areas. Yet, they also stress the need for clear guidelines, robust training quality assurance, and preservation of patient safety standards before expanding prescription rights to non-allopathic physicians .
Public Health Implications
This policy potentially expands the healthcare workforce capable of delivering primary care and essential allopathic treatments in Maharashtra, a state with a diverse and large population. Proponents argue this hybrid model can bridge gaps in medical access and improve service delivery, especially in public hospitals and remote settings where staffing shortages are acute.
However, critics warn about possible risks related to the scope of practice and training adequacy. The CCMP is a one-year course, distinct from full allopathic medical education, raising concerns about the comprehensiveness of pharmacological knowledge and clinical skills necessary for safe prescribing. The IMA’s opposition largely revolves around patient safety and the professional boundaries between distinctly trained medical systems.
Given these competing perspectives, governance mechanisms like maintaining separate registers, restrictive prescribing protocols, and strengthened oversight could be crucial for mitigating safety risks while enabling pragmatic use of human resources .
Limitations and Counterarguments
The ongoing court challenge and stay orders reflect unsettled judicial consensus on the legality and prudence of the policy. It also underscores the tension between medical professional bodies advocating strict qualification standards and public health authorities seeking expanded healthcare delivery models.
Further scrutiny is needed on the outcomes and patient safety data as this policy rolls out, including long-term monitoring of CCMP-qualified homeopaths practicing in allopathic domains. Transparency in curriculum quality, adherence to evidence-based treatment protocols, and clear public communication about practitioner roles will be critical.
Practical Takeaways for Readers
For the general public and patients, understanding that CCMP-qualified homeopaths are authorized to prescribe certain allopathic medicines under specific training limits is important. Patients should verify practitioner credentials and clarify scope of practice, especially when receiving mixed modality treatments.
Health consumers are encouraged to maintain open communication with all healthcare providers and to consult qualified allopathic practitioners for conditions requiring specialized or comprehensive care. Awareness about the distinctions between homeopathy, CCMP certification, and full-fledged allopathic medicine can empower safe and informed health decisions.
Medical Disclaimer
This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
-
Maharashtra Medical Education and Drugs Department. Circular on registration of CCMP-qualified homeopaths with MMC. 2025.https://medicaldialogues.in/news/health/maha-medical-council-told-to-register-ccmp-qualified-homeopaths-doctors-cry-foul-154734
